Relationship of CRP, IL-6, and fibrinogen with right ventricular structure and function: The MESA-Right Ventricle Study

International Journal of Cardiology

Volumn 168, Issue 4, 2013, Pages 3818-3824

  Harhay, Michael O ^a,b   Tracy, Russell P ^c   Bagiella, Emilia ^d   Barr, R Graham ^e   Pinder, Diane ^b   Hundley, W Gregory ^f   Bluemke, David A ^g   Kronmal, Richard A ^h   Lima, Joao A C ⁱ   Kawut, Steven M ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF VERMONT   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

^f WAKE FOREST SCHOOL OF MEDICINE   (United States)

^g NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING   (United States)

^h UNIVERSITY OF WASHINGTON   (United States)

ⁱ JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Heart failure; Multi Ethnic Study of Atherosclerosis; Right ventricle; Systemic inflammation

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; INTERLEUKIN 6;

ADULT; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR PARAMETERS; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HEART DISEASE; HEART RIGHT VENTRICLE EJECTION FRACTION; HEART RIGHT VENTRICLE ENDDIASTOLIC VOLUME; HEART RIGHT VENTRICLE ENDSYSTOLIC VOLUME; HEART RIGHT VENTRICLE FUNCTION; HEART RIGHT VENTRICLE MASS; HEART STROKE VOLUME; HUMAN; INFLAMMATION; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN ANALYSIS; SENSITIVITY ANALYSIS;

HEART FAILURE; MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS; RIGHT VENTRICLE; SYSTEMIC INFLAMMATION;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; COHORT STUDIES; ETHNIC GROUPS; FEMALE; FIBRINOGEN; HEART VENTRICLES; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; VENTRICULAR FUNCTION, RIGHT;

EID: 84886283330     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.06.028     Document Type: Article

References (44)

1. Y. Iwashima, T. Horio, K. Kamide, H. Rakugi, T. Ogihara, and Y. Kawano C-reactive protein, left ventricular mass index, and risk of cardiovascular disease in essential hypertension Hypertens Res 30 2007 1177 1185
2. C. Tsioufis, P. Stougiannos, and A. Kakkavas Relation of left ventricular concentric remodeling to levels of C-reactive protein and serum amyloid A in patients with essential hypertension Am J Cardiol 96 2005 252 256
3. F. Assadi C-reactive protein and incident left ventricular hypertrophy in essential hypertension Pediatr Cardiol 28 2007 280 285
4. E. Rosello-Lleti, M. Rivera, and L. Martinez-Dolz Inflammatory activation and left ventricular mass in essential hypertension Am J Hypertens 22 2009 444 450
5. C. Chrysohoou, C. Pitsavos, and J. Barbetseas Chronic systemic inflammation accompanies impaired ventricular diastolic function, detected by Doppler imaging, in patients with newly diagnosed systolic heart failure (Hellenic Heart Failure Study) Heart Vessels 24 2009 22 26
6. P.M. Ridker, N.P. Paynter, N. Rifai, J.M. Gaziano, and N.R. Cook C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men Circulation 118 2008 2243 2251
7. P.M. Ridker, J.E. Buring, N. Rifai, and N.R. Cook Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score JAMA 297 2007 611 619
8. S. Kaptoge, E. Di Angelantonio, and L. Pennells C-reactive protein, fibrinogen, and cardiovascular disease prediction N Engl J Med 367 2012 1310 1320
9. H. Bruunsgaard, and B.K. Pedersen Age-related inflammatory cytokines and disease Immunol Allergy Clin North Am 23 2003 15 39
10. A.D. Pradhan, J.E. Manson, N. Rifai, J.E. Buring, and P.M. Ridker C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus JAMA 286 2001 327 334
11. D.A. Gorog Prognostic value of plasma fibrinolysis activation markers in cardiovascular disease J Am Coll Cardiol 55 2010 2701 2709
12. J. Danesh, S. Lewington, and S.G. Thompson Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis JAMA 294 2005 1799 1809
13. S.K. Venugopal, S. Devaraj, and I. Jialal C-reactive protein decreases prostacyclin release from human aortic endothelial cells Circulation 108 2003 1676 1678
14. S.K. Venugopal, S. Devaraj, and I. Jialal Effect of C-reactive protein on vascular cells: evidence for a proinflammatory, proatherogenic role Curr Opin Nephrol Hypertens 14 2005 33 37
15. S.K. Venugopal, S. Devaraj, I. Yuhanna, P. Shaul, and I. Jialal Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells Circulation 106 2002 1439 1441
16. S. Kaptoge, E. Di Angelantonio, and G. Lowe C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis Lancet 375 2010 132 140
17. F. Wensley, P. Gao, and S. Burgess Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data Br Med J 342 2011
18. N. Kherbeck, M.C. Tamby, and G. Bussone The role of inflammation and autoimmunity in the pathophysiology of pulmonary arterial hypertension Clin Rev Allergy Immunol 44 2011 31 38
19. E. Soon, A.M. Holmes, and C.M. Treacy Elevated levels of inflammatory cytokines predict survival in idiopathic and familial pulmonary arterial hypertension Circulation 122 2010 920 927
20. M. Humbert, G. Monti, and F. Brenot Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension Am J Respir Crit Care Med 151 1995 1628 1631
21. The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis Lancet 379 2012 1214 1224
22. N. Sarwar, A.S. Butterworth, and D.F. Freitag Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies Lancet 379 2012 1205 1213
23. B. Keavney, J. Danesh, and S. Parish Fibrinogen and coronary heart disease: test of causality by 'Mendelian randomization' Int J Epidemiol 35 2006 935 943
24. M.M. Can, I.H. Tanboga, and H.C. Demircan Enhanced hemostatic indices in patients with pulmonary arterial hypertension: an observational study Thromb Res 126 2010 280 282
25. J. Zhang, Y. Zhang, and N. Li Potential diagnostic biomarkers in serum of idiopathic pulmonary arterial hypertension Respir Med 103 2009 1801 1806
26. S.M. Kawut, R.G. Barr, and W.C. Johnson Matrix metalloproteinase-9 and plasminogen activator inhibitor-1 are associated with right ventricular structure and function: the MESA-RV Study Biomarkers 15 2010 731 738
27. H. Chahal, C. Johnson, and H. Tandri Relation of cardiovascular risk factors to right ventricular structure and function as determined by magnetic resonance imaging (results from the multi-ethnic study of atherosclerosis) Am J Cardiol 106 2010 110 116
28. S. Natori, S. Lai, and J.P. Finn Cardiovascular function in multi-ethnic study of atherosclerosis: normal values by age, sex, and ethnicity AJR Am J Roentgenol 186 2006 S357 S365
29. M. Cushman, E.S. Cornell, P.R. Howard, E.G. Bovill, and R.P. Tracy Laboratory methods and quality assurance in the Cardiovascular Health Study Clin Chem 41 1995 264 270
30. E.A. Hoffman, R. Jiang, and H. Baumhauer Reproducibility and validity of lung density measures from cardiac CT Scans - The Multi-Ethnic Study of Atherosclerosis (MESA) Lung Study Acad Radiol 16 2009 689 699
31. J.L. Hankinson, S.M. Kawut, E. Shahar, L.J. Smith, K.H. Stukovsky, and R.G. Barr Performance of American Thoracic Society-recommended spirometry reference values in a multiethnic sample of adults: the multi-ethnic study of atherosclerosis (MESA) lung study Chest 137 2010 138 145
32. K.J. Rothman, and S. Greenland Modern epidemiology 2nd ed. 1998 Lippincott-Raven Philadelphia, PA
33. T.J. Wang, P. Gona, and M.G. Larson Multiple biomarkers for the prediction of first major cardiovascular events and death N Engl J Med 355 2006 2631 2639
34. G.K. Hansson Inflammation, atherosclerosis, and coronary artery disease N Engl J Med 352 2005 1685 1695
35. S.K. Mehta, J.E. Rame, and A. Khera Left ventricular hypertrophy, subclinical atherosclerosis, and inflammation Hypertension 49 2007 1385 1391
36. M. Dahl, J. Vestbo, J. Zacho, P. Lange, A. Tybjaerg-Hansen, and B.G. Nordestgaard C reactive protein and chronic obstructive pulmonary disease: a Mendelian randomisation approach Thorax 66 2011 197 204
37. P. Elliott, J.C. Chambers, and W. Zhang Genetic Loci associated with C-reactive protein levels and risk of coronary heart disease JAMA 302 2009 37 48
38. R. Quarck, T. Nawrot, B. Meyns, and M. Delcroix C-reactive protein: a new predictor of adverse outcome in pulmonary arterial hypertension J Am Coll Cardiol 53 2009 1211 1218
39. B. Sztrymf, R. Souza, and L. Bertoletti Prognostic factors of acute heart failure in patients with pulmonary arterial hypertension Eur Respir J 35 2010 1286 1293
40. A. Chaouat, L. Savale, and C. Chouaid Role for interleukin-6 in COPD-related pulmonary hypertension Chest 136 2009 678 687
41. L. Savale, L. Tu, and D. Rideau Impact of interleukin-6 on hypoxia-induced pulmonary hypertension and lung inflammation in mice Respir Res 10 2009 6
42. M.K. Steiner, O.L. Syrkina, N. Kolliputi, E.J. Mark, C.A. Hales, and A.B. Waxman Interleukin-6 overexpression induces pulmonary hypertension Circ Res 104 2009 236 244
43. W.J. Jabs, B.A. Logering, and P. Gerke The kidney as a second site of human C-reactive protein formation in vivo Eur J Immunol 33 2003 152 161
44. W.J. Evans Skeletal muscle loss: cachexia, sarcopenia, and inactivity Am J Clin Nutr 91 2010 1123S 1127S